A carregar...
Nivolumab treatment for advanced renal cell carcinoma: Considerations for clinical practice
BACKGROUND: Nivolumab is an important new therapy option for patients with advanced renal cell carcinoma, and has a different mechanism of action compared with vascular endothelial growth factor -targeted therapies. It is a programmed death 1 immune checkpoint inhibitor antibody with response patter...
Na minha lista:
| Publicado no: | Urol Oncol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6863156/ https://ncbi.nlm.nih.gov/pubmed/28259541 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urolonc.2017.01.017 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|